Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus.

Juan Aitken SaavedraRafael G LundJaime GonzálezRomina HuenchunaoIlia Perez-VallespirIrene Morales-BozoBlanca UrzúaSandra Chaves TarquinioAndrea Maturana-RamírezJosué MartosRicardo Fernandez-RamiresAlfredo Molina-Berríos

Published in: Acta odontologica Scandinavica (2018)

The antifungal therapies could be more effective if it consider, qualitative salivary characteristics as pH, that could determine the susceptibility of species of Candida to at least to nystatin, which is the most used antifungal for treatment to oral candidiasis in patients with DM2.

Keyphrases

candida albicans
biofilm formation
systematic review
genetic diversity
type diabetes